UBS Group’s CERo Therapeutics CERO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.3K Buy
2,625
+491
+23% +$4.73K ﹤0.01% 6983
2025
Q1
$31.2K Buy
+2,134
New +$31.2K ﹤0.01% 6624
2023
Q1
Sell
-1
Closed -$29.7K 9122
2022
Q4
$29.7K Hold
1
﹤0.01% 6080
2022
Q3
$15K Buy
+1
New +$15K ﹤0.01% 6737
2022
Q2
Hold
0
7695